Lower HDAC6 mRNA expression and promoter hypomethylation are associated with RA susceptibility

Tzu-Jung Fang1, Chia-Hui Lin2, Yuan-Zhao Lin2

  • 1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Taiwan; Division of Geriatrics and Gerontology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan.

Abstract

Insights

Lower Histone deacetylases 6 (HDAC6) mRNA expression and promoter hypomethylation are linked to rheumatoid arthritis (RA) susceptibility in patients. These findings suggest HDAC6 inhibitors may not be suitable for treating RA.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Histone deacetylases 6 (HDAC6) inhibitors show promise in rheumatoid arthritis (RA) rodent models.
  • However, reduced HDAC6 expression in RA patients' synovial fibroblasts raises concerns about inhibitor efficacy.
  • This study investigates HDAC6 mRNA expression and promoter methylation in RA patients.

Purpose of the Study:

  • To examine the role of HDAC6 mRNA expression in rheumatoid arthritis (RA).
  • To analyze HDAC6 promoter methylation patterns in RA patients.
  • To determine the association between HDAC6 expression, methylation, and RA risk.

Main Methods:

  • Extracted DNA and RNA from peripheral blood mononuclear cells (PBMCs) of 138 RA patients and 102 healthy controls.
  • Utilized pyrosequencing for HDAC6 promoter methylation analysis.
  • Employed quantitative real-time polymerase chain reaction (qRT-PCR) for HDAC6 mRNA expression quantification.

Main Results:

  • RA patients exhibited significantly lower HDAC6 mRNA expression and HDAC6 promoter hypomethylation compared to controls.
  • Specific CpG sites (-229, -225, -144, -142) in the HDAC6 promoter were hypomethylated in RA patients.
  • HDAC6 mRNA expression and promoter methylation were positively correlated and associated with RA risk.
  • HDAC6 knockdown in cell lines increased inflammatory cytokines TNF-α and IL-6.

Conclusions:

  • Lower HDAC6 mRNA expression and promoter hypomethylation characterize rheumatoid arthritis (RA) patients.
  • Both reduced HDAC6 expression and promoter hypomethylation are associated with RA susceptibility.
  • HDAC6 inhibitors may not be an appropriate therapeutic strategy for RA patients.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K